title: Apolipoprotein E genotype and LRP1 polymorphisms in patients with different clinical types of metachromatic leukodystrophy.
abstract: Metachromatic leukodystrophy (MLD) is a severe, neurodegenerative, metabolic disease which is caused by deficient activity of arylsulfatase A (ARSA). Sulfatides and other substrates of ARSA are stored in central and peripheral nervous systems, and in some other organs. Accumulated sulfatides are especially toxic to oligodendrocytes and Schwann cells leading to progressive demyelination. The kind of apolipoprotein E (apoE) isoform is of essential significance for the modulation of sulfatide quantity in the brain as apoE4 contains more sulfatides than apoE3. Taking into consideration the fact that apoE4 leads to the loss of sulfatides in CSF of Alzheimer's disease patients, we examined if apoE isoforms display any impact on clinical outcome in patients with different forms of MLD in whom sulfatides accumulate. The significant association of age at the onset of MLD symptoms with APOE ε2/ε3/ε4 and LRP1 c.766C>T polymorphisms was shown in multivariate stepwise regression analysis, in which other factors known to affect age at onset of the disease, i.e. clinical type of MLD, family connection of the patient and sex were also analyzed. As expected, the clinical type of MLD explained about 80% of the variance of the dependent variable. The impact of both polymorphisms on age of onset of the disease was considerably lower: 2.0% in the case of APOE polymorphism and 1.0% in the case of LRP1 polymorphism. Thus, the clinical outcome in MLD patients is related principally to the genotype of the ARSA gene, while the polymorphisms in the APOE and LRP1 genes are only slightly modifying factors.
authors.affiliation: Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland. alugipin@yahoo.com
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Ługowska
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Musielak
authors.forename: Ewa
authors.initials: E
authors.lastname: Jamroz
authors.forename: Antoni
authors.initials: A
authors.lastname: Pyrkosz
authors.forename: Tomasz
authors.initials: T
authors.lastname: Kmieć
authors.forename: Anna
authors.initials: A
authors.lastname: Tylki-Szymańska
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Bednarska-Makaruk
mesh_terms: D000293:Adolescent; D000328:Adult; D000483:Alleles; D001057:Apolipoproteins E / Q000235:genetics*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007966:Leukodystrophy, Metachromatic / Q000235:genetics*; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000235:genetics*; D008297:Male; D011110:Polymorphism, Genetic; D055815:Young Adult
chemical_list: D001057:Apolipoproteins E; D026503:Low Density Lipoprotein Receptor-Related Protein-1
keywords: AD; ARSA; Alzheimer's disease; Apolipoprotein E; Aβ; LDL receptor-related protein; LRP1 protein; Lysosomal storage disease; MLD; Metachromatic leukodystrophy; apoE; apolipoprotein E; arylsulfatase A; beta-amyloid; metachromatic leukodystrophy